PALLONI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 444
EU - Europa 86
AS - Asia 29
AF - Africa 5
SA - Sud America 3
Totale 567
Nazione #
US - Stati Uniti d'America 441
IT - Italia 36
GB - Regno Unito 18
CN - Cina 12
VN - Vietnam 11
DE - Germania 8
MK - Macedonia 6
IN - India 5
ZA - Sudafrica 5
FR - Francia 4
RS - Serbia 4
CA - Canada 3
CL - Cile 3
CZ - Repubblica Ceca 3
FI - Finlandia 3
UA - Ucraina 2
ID - Indonesia 1
RU - Federazione Russa 1
SE - Svezia 1
Totale 567
Città #
Santa Cruz 56
Fairfield 43
Houston 29
Wilmington 29
Buffalo 28
Seattle 27
Woodbridge 25
Cambridge 23
Ashburn 19
Southend 14
Bologna 11
Dong Ket 9
Las Vegas 9
Ann Arbor 8
Chicago 7
Milpitas 4
Muizenberg 4
University Park 4
Altedo 3
Beijing 3
Clearwater 3
Helsinki 3
Los Angeles 3
Novi Beograd 3
Chandler 2
Modena 2
New York 2
Prilep 2
Provo 2
Redmond 2
Renqiu 2
Riva 2
San Diego 2
San Jose 2
Scranton 2
Skopje 2
Toronto 2
Andover 1
Bengaluru 1
Calderara Di Reno 1
Costabissara 1
Dallas 1
Dulles 1
Forlì 1
Gardone Val Trompia 1
Guangzhou 1
Hangzhou 1
Henderson 1
Jakarta 1
Modderfontein 1
New Kensington 1
Ottawa 1
Palo Alto 1
Pasadena 1
Phoenix 1
Piacenza 1
Rome 1
Saint Louis 1
San Francisco 1
Santiago 1
Serra 1
Shanghai 1
Wuhan 1
Yellow Springs 1
Zogno 1
Totale 421
Nome #
Membrane human equilibrative nucleoside transporter 1 is associated with a high proliferation rate and worse survival in resected intrahepatic cholangiocarcinoma patients not receiving adjuvant treatments, file e1dcb331-8d2e-7715-e053-1705fe0a6cc9 115
Metronomic capecitabine vs. best supportive care in Child-Pugh B hepatocellular carcinoma: A proof of concept, file e1dcb332-0acc-7715-e053-1705fe0a6cc9 94
The role of metronomic capecitabine for treatment of recurrent hepatocellular carcinoma after liver transplantation, file e1dcb333-a549-7715-e053-1705fe0a6cc9 76
SUSTAINED COMPLETE RESPONSE OF ADVANCED HEPATOCELLULAR CARCINOMA WITH METRONOMIC CAPECITABINE: A REPORT OF THREE CASES, file e1dcb331-e20b-7715-e053-1705fe0a6cc9 57
Bone metastases in biliary cancers: A multicenter retrospective survey, file e1dcb332-7913-7715-e053-1705fe0a6cc9 56
Adjuvant treatment in biliary tract cancer, file e1dcb332-c588-7715-e053-1705fe0a6cc9 45
Searching for novel multimodal treatments in oligometastatic pancreatic cancer, file e1dcb336-bf6d-7715-e053-1705fe0a6cc9 45
Challenges in Repurposing Drugs in COVID-19 Pandemic. Debating on Potential New Refinements, file e1dcb336-fb0d-7715-e053-1705fe0a6cc9 37
Wilson disease, ABCC2 c.3972C > T polymorphism and primary liver cancers: suggestions from a familial cluster, file e1dcb336-6e55-7715-e053-1705fe0a6cc9 32
Is post-transplant chemotherapy feasible in liver transplantation for colorectal cancer liver metastases?, file e1dcb337-4b0e-7715-e053-1705fe0a6cc9 12
INTRAHEPATIC CHOLANGIOCARCINOMA DEVELOPMENT IN A PATIENT WITH A NOVEL BAP1 GERMLINE MUTATION AND LOW EXPOSURE TO ASBESTOS, file e1dcb336-d2ca-7715-e053-1705fe0a6cc9 9
Membrane localization of human equilibrative nucleoside transporter 1 in tumor cells may predict response to adjuvant gemcitabine in resected cholangiocarcinoma patients, file e1dcb32e-2e82-7715-e053-1705fe0a6cc9 4
State of the art biological therapies in pancreatic cancer, file e1dcb32d-d8dd-7715-e053-1705fe0a6cc9 3
Specific Toxicity of Maintenance Olaparib Versus Placebo in Advanced Malignancies: A Systematic Review and Meta-analysis, file e1dcb333-cd9f-7715-e053-1705fe0a6cc9 3
INTRAHEPATIC CHOLANGIOCARCINOMA DEVELOPMENT IN A PATIENT WITH A NOVEL BAP1 GERMLINE MUTATION AND LOW EXPOSURE TO ASBESTOS, file e1dcb339-a5b3-7715-e053-1705fe0a6cc9 3
Aspirin for cholangiocarcinoma prevention: New targets to shift the dogma from ascertained risk to possible prevention, file e1dcb330-bc1e-7715-e053-1705fe0a6cc9 2
TERC AND MYC COPY NUMBER GAIN AS POWERFUL GENETIC MARKERS FOR INTRADUCTAL PAPILLARY NEOPLASMS OF THE PANCREAS, file e1dcb330-ff5b-7715-e053-1705fe0a6cc9 1
Should we incorporate ablative radiotherapy in standard treatment of advanced intrahepatic cholangiocarcinoma?, file e1dcb332-a543-7715-e053-1705fe0a6cc9 1
Dual immune checkpoint blockade in hepatocellular carcinoma: where do we stand?, file e1dcb339-6800-7715-e053-1705fe0a6cc9 1
Hacking pancreatic cancer: Present and future of personalized medicine, file e1dcb339-8eff-7715-e053-1705fe0a6cc9 1
Molecular features and targeted therapies in extrahepatic cholangiocarcinoma: Promises and failures, file e1dcb339-e735-7715-e053-1705fe0a6cc9 1
Totale 598
Categoria #
all - tutte 876
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 876


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/20182 0000 00 00 2000
2018/20194 0000 00 10 1002
2019/2020103 0002 613 1720 171279
2020/2021171 71745 519 1819 23152118
2021/2022226 12131315 274 713 1757228
2022/202388 1086010 00 00 0000
Totale 598